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Chlamydia suis is a swine pathogen that has also recently been found to cause
zoonotic infections of the human eye, pharynx, and gastrointestinal tract. Many strains
contain a tetracycline class C gene [tet(C)] cassette that confers tetracycline resistance.
The cassette was likely originally acquired by horizontal gene transfer from a Gram-
negative donor after the introduction of tetracycline into animal feed in the 1950s.
Various research groups have described the capacity for different Chlamydia species
to exchange DNA by homologous recombination. Since over 90% of C. suis strains
are tetracycline resistant, they represent a potential source for antibiotic-resistance
spread within and between Chlamydiaceae species. Here, we examined the genetics
of tet(C)-transfer among C. suis strains. Tetracycline-sensitive C. suis strain S45 was
simultaneously or sequentially co-infected with tetracycline-resistant C. suis strains
in McCoy cells. Potential recombinants were clonally purified by a harvest assay
derived from the classic plaque assay. C. suis strain Rogers132, lacking transposases
IS200 and IS605, was the most efficient donor, producing two unique recombinants
detected in three of the 56 (5.4%) clones screened. Recombinants were found to have
a minimal inhibitory concentration (MIC) of 8–16 µg/mL for tetracycline. Resistance
remained stable over 10 passages as long as recombinants were initially grown in
tetracycline at twice the MIC of S45 (0.032 µg/mL). Genomic analysis revealed that
tet(C) had integrated into the S45 genome by homologous recombination at two
unique sites depending on the recombinant: a 55 kb exchange between nrqF and
pckG, and a 175 kb exchange between kdsA and cysQ. Neither site was associated
with inverted repeats or motifs associated with recombination hotspots. Our findings
show that cassette transfer into S45 has low frequency, does not require IS200/IS605
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transposases, is stable if initially grown in tetracycline, and results in multiple genomic
configurations. We provide a model for stable cassette transfer to better understand
the capability for cassette acquisition by Chlamydiaceae species that infect humans, a
matter of public health importance.
Keywords: Chlamydia, tetracycline resistance, transposon, homologous recombination, genomic island,
Chlamydia suis, Chlamydia trachomatis
INTRODUCTION
Bacteria develop resistance to antibiotics either as a result of
mutation in their chromosomal genes or from acquisition of
antibiotic resistance genes by horizontal gene transfer (HGT).
Reports of bacterial resistance to antimicrobial agents have
occurred almost simultaneously with their first introduction in
the late 1930s (Davies and Davies, 2010). Resistance through
mutation or HGT is promoted by sub-inhibitory concentrations,
broad-spectrum and high doses of antibiotics; patient non-
compliance with treatment regimens; and antibiotic use in
mammalian and avian species bred for human consumption
(Andersson and Hughes, 2014). These latter practices have
led to an alarming increase in microbial pathogen resistance
such as colistin-resistant Escherichia coli and multidrug-resistant
Staphylococcus aureus. Both have been isolated from pigs and
zoonotically transmitted to human hosts (Oppliger et al., 2012;
Liu et al., 2016), adding to the crisis in public health infectious
disease control (Capita and Alonso-Calleja, 2013; Blair et al.,
2015).
Of the five families of obligate intracellular bacteria, including
Ehrlichiaceae, Anaplasmataceae, Rickettsiaceae, Coxiellaceae and
Chlamydiaceae, only Chlamydia suis has been reported to
naturally display antibiotic resistance by acquisition of a
resistance gene: a tetracycline resistance class C gene [tet(C)]-
containing cassette that was acquired by HGT (Dugan et al.,
2004; Biswas et al., 2008). C. suis is a pig pathogen that causes
conjunctivitis, pneumonia, diarrhea/enteritis and reproductive
disorders (Schautteet and Vanrompay, 2011; Hoffmann et al.,
2015). It has also recently been associated with zoonoses
including trachoma (a chronic ocular disease) (Dean et al., 2013),
ocular infection in abattoir workers (De Puysseleyr et al., 2014)
and asymptomatic nasal, pharyngeal, and intestinal infections in
farmers (De Puysseleyr et al., 2015).
Tetracyclines, including doxycycline, are used to treat a
variety of bacteria including all Chlamydia spp. and, in
particular, complicated infections caused by the human pathogen
Chlamydia trachomatis (Kohlhoff and Hammerschlag, 2015).
Since both C. suis and C. trachomatis infect the human
conjunctiva and rectum, the in vivo opportunity for HGT of the
cassette to C. trachomatis is a real concern. Indeed, C. suis and
C. trachomatis co-infections have already been reported among
trachoma patients (Dean et al., 2013).
Tetracycline resistance in C. suis is conferred by a variable
tet(C)-containing cassette that encodes an eﬄux pump to export
tetracycline from infected cells. The cassettes are comprised
of two or three segments (Dugan et al., 2004; Joseph et al.,
2016). One segment, present in all strains, has tet(C) and the
tetracycline repressor gene tetR(C). Another contains replication
genes repAC as well as mobilization genes mobABCDE, also
present in all strains. A third has two insertion sequences
IS605 and IS200 that contain transposases. Dugan et al. (2007)
showed that these transposases were active in an Escherichia
coli-based assay. In another study (Suchland et al., 2009), a co-
infection model was used to successfully generate tetracycline
resistant (tetR) C. trachomatis L2 strains from co-infection
of tetR C. suis R19 with a tetracycline sensitive (tetS) L2
strain. However, cassettes lacking the transposases have not
been examined for their recombinogenic potential. Here, we
tested the requirement of IS200/IS605 transposases for tet(C)-
containing cassette transfer and developed a model to study
cassette transfer among chlamydiae in the presence and absence
of tetracycline.
MATERIALS AND METHODS
Chlamydia Strains, Cell Culture, and
Tetracycline Susceptibility
Table 1 describes the strains used in this study. All strains
were individually propagated in McCoy cells prior to density
gradient purification as we previously described (Read et al., 2013;
Joseph et al., 2016). McCoy cells were screened for Mycoplasma
contamination before use (Universal Mycoplasma Detection Kit,
ATCC R© 30-1012KTM, Manassas, VA, USA).
The in vitro tetracycline susceptibility was determined as the
minimal inhibitory concentration (MIC) according to Suchland
et al. (2003) with minor changes. Briefly, each chlamydial strain
was inoculated onto 20 wells of a 48-well plate (E & K Scientific,
Santa Clara, CA, USA) seeded with McCoy cells at a multiplicity
of infection (MOI) of 0.5 or 1 depending on the infectivity of
the strain. After inoculation of cells, the plate was centrifuged at
1500 RPM (Sorvall LegendXTR) for 1 h at 37◦C. A tetracycline
(Sigma-Aldrich, St. Louis, MO, USA) stock solution (10 mg/mL)
in ddH2O was used for a twofold dilution in propagation medium
consisting of 450 mL Minimal Essential Medium alpha (MEMa,
Life Technologies, Carlsbad, CA, USA), 10% Fetal Bovine
Serum (FBS, JR Scientific, Woodland, CA, USA), 15 ml sodium
bicarbonate (2.8%) (Thermo Fisher Scientific, Waltham, MA,
USA), 10 ml glucose (45%) (Fisher Scientific), 10 mM HEPES
(Life Technologies) and 1.4 µg/mL Cycloheximide (Sigma-
Aldrich) with final concentrations ranging of 0.002 to 256 µg/mL
(18 concentrations). After centrifugation, the chlamydial inocula
were aspirated and replaced with the serial tetracycline dilutions.
Two infected and two uninfected wells received media without
tetracycline and served as positive and negative controls,
respectively. Cells were fixed with methanol (−20◦C) for 10 min
after 24–36 h of incubation, depending on the developmental
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TABLE 1 | Characteristics of Chlamydia suis strains used in this study.
Strains Site/Disease Location Isolation date MIC (µg/mL) Cassette class Reference
S45 Feces Austria 1960s 0.016 None Kaltenboeck et al., 1993a
Rogers132 Intestine, lung, conjunctiva Nebraska, USA 1996 8 II Dugan et al., 2004a
R19 Enteritis Nebraska, USA 1992 16 I Dugan et al., 2004a
R27 Enteritis Nebraska, USA 1993 8 IV Dugan et al., 2004a
aSamples obtained from Dr. Art Andersen’s collection (maintained and curated in Dr. Deborah Dean’s lab).
cycle of the strain, at 37◦C in 5% CO2. Chlamydial inclusions
were detected by direct immunofluorescence using Chlamydia
Confirmation Pathfinder (Bio-Rad, Hercules, CA, USA). The
MICs were evaluated by analyzing size and morphology as well
as the number of inclusions (200 X, Nikon Eclipse Microscope
and SPOT imaging software; Diagnostic Instruments, Inc.,
Sterling Heights, MI, USA). We determined the MIC transition
point (MICTP) to be the tetracycline concentrations where 90%
or more of the inclusions displayed alterations in size and
morphology. Furthermore, the actual MIC was set at twofold
higher concentrations (two times the MICTP) as defined by
Suchland et al. (2003).
Generation and Clonal Isolation of
Recombinants
Supplementary Figure S1 shows the schematic and timeline
for generation of recombinants. Two different recombination
protocols were applied for co-infections. For Protocol 1
(recipient-first before co-infection with donor), confluent
monolayers grown in shell vials were inoculated with tetS S45
at an MOI of 4, centrifuged and incubated for 24 h before
the addition of tetR parental strains Rogers132, R19, or R27
at an MOI of 0.5. Tetracycline challenge was at 2 µg/mL
(1/2 MICTP Rogers132) as described below. For protocol 2
(simultaneous co-infection), tetS S45 was first grown in McCoy
cell monolayers in shell vials to reach 100% infection; 25–50 µL
of the infected culture were transferred to a new shell vial with
a 80–100% confluent McCoy cell monolayer and simultaneously
or immediately consecutively co-infected with tetR R19, tetR R27,
or tetR Rogers132. Inoculation was followed by centrifugation for
1 h at 1500 RPM. Tetracycline challenge was with 0.25 µg/mL
(8x MIC S45) as described below (Supplementary Figure S1).
For each co-infection, three conditions and two controls
(single infection with each parental strain) were used. Condition
A did not contain any tetracycline (no tet); Condition B
contained sub-inhibitory concentrations of tetracycline (1/2
MICTP for S45; 0.004 (µg/mL); and Condition C contained
two times the MIC of S45 (0.032 µg/mL). Co-infected cultures
were propagated for 72 h, sonicated once (20% amplitude,
Sonic Dismembrator Ultrasonic Processor, Fisher Scientific), and
new shell vials were infected to produce 100% infection. Each
condition was either directly challenged with tetracycline (2 or
0.25 µg/mL depending on Protocol 1 or 2 described above) or
passaged once in propagation medium without antibiotics prior
to the tetracycline challenge. Following the challenge for 36–
72 h depending on the developmental cycle of the strain, infected
cultures were sonicated, and the inoculum was used to perform
a harvest assay derived from the classic plaque assay, PCR and
sequencing of PCR products to identify putative recombinants
(see below, Supplementary Figure S1).
Isolation of clonally pure putative recombinants was
accomplished using a modified cell culture harvest assay protocol
(harvest assay), which derives from the classic plaque assay
and is closely related to the shotgun cell culture harvest assay
described by Somboonna et al. (2008). Briefly, the first well
of a 6-well plate with 60% confluent McCoy monolayers was
inoculated with the desired culture; seven serial 10-fold dilutions
were performed, of which dilutions 2–7 were applied to wells
1–6. After 24 h, 2 mL of agarose gel (0.5% agarose, Lonza,
Rockland, ME, USA) in phenol-red free MEM (Gibco), 10%
FBS and 1 µg/ml Cycloheximide was added and topped with
propagation medium. After incubation for 4–16 h, the well
with detectable but low-level infection was chosen to select
individual inclusions (no neighboring inclusions) at 200x
magnification. Individual inclusions were picked with a sterile
transfer pipet (Fisher Scientific) by punching a hole of 1–2 mm
in diameter through the agarose; the plug was then sonicated
in propagation medium and used to inoculate one shell vial per
picked inclusion containing 500 µL propagation medium. The
clones were propagated until the infection reached 100% (3–5
passages). Material from these clones was sonicated and frozen at
−80◦C, and a paired vial was collected for PCR and sequencing
(Somboonna et al., 2011).
Identification of Putative Recombinants
for Genome Sequencing
DNA from collected clones was extracted using the
Roche High Pure PCR Product Purification Kit (Roche,
Pleasanton, CA, USA), and PCR was performed as previously
described (Somboonna et al., 2008). All primers are listed in
Supplementary Table S1. Clones were considered putative
recombinants if they had the following characteristics by PCR:
positive for the correct size band for the tet(C) gene; positive for
the intergenic region (IGR) between the polymorphic membrane
protein gene (pmp)B and pmpC using primers specific for
S45; negative for the pmpC region using primers specific for
Rogers132; and positive for the major outer membrane protein
A gene (ompA) with confirmation of the S45 ompA genotype by
Sanger sequencing.
Putative clonal recombinants were then propagated in
0.063 µg/mL tetracycline (4x MIC of S45) to grow stocks for
whole-genome sequencing, MIC determination, and the tet(C)
stability assay (see below). After the first passage, the harvest
assay was performed a second time to ensure clonal purity.
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Picked clones were either grown as described above or directly
picked and inoculated into 100 µL HBSS (Gibco) prior to DNA
extraction, PCR, and ompA sequencing.
Genome Sequencing
Stocks of clonally purified putative recombinants were treated
with DNase prior to gDNA purification as described previously
(Somboonna et al., 2011). Libraries for sequencing were prepared
from 0.5 to 1 µg of genomic DNA. Illumina MiSeq libraries
were constructed using the Nextera kit and sequenced using
the 250 bp paired end protocol on a MiSeq instrument. The
resulting sequence data was assembled de novo using the SPAdes
(Bankevich et al., 2012) software. The CONTIGuator web service
(Galardini et al., 2011) was used to map assembled contigs
against the Rogers132 strain. We visualized the structure of the
assemblies aligned against individual regions of the chromosome
using the Bandage graph visualization (Wick et al., 2015)
software and its integrated BLAST tool. Querying of short
sequences against the raw sequence reads in FASTQ format
was performed using the R ShortRead (Morgan et al., 2009)
package.
The raw genome data generated for this study are deposited in
the SRA database: accession no. SRP096281.
Analysis of Homologous Recombination
and tet(C)-Containing Cassette Insertion
into C. suis Strain S45
We used the parsnp rapid genome alignment tool, which is
part of the Harvest suite (Treangen et al., 2014) to identify
regions of genome exchange in the recombinants. De novo
assembled contigs of the recombinants were mapped against the
S45 recipient genome reference and compared to the pattern of
SNPs obtained when the Rogers132 donor was mapped against
S45. Mosaic regions introduced by homologous recombination
events appeared as clusters of ‘Rogers132-like’ SNPs in the
background of the S45 genome. The approximate boundaries of
recombination events were mapped as the edges of continuous
runs of inserted SNPs.
‘SNP Painting’ to Find Regions of
Homologous Recombination in Mixed
Cultures
We noted from preliminary analysis that recombinant DNA
preparations in some cases also contained residual DNA from
donor and/or recipient strains. To visualize the proportion of
reads containing the donor and recipient backbone, we used a
technique we called ‘SNP painting.’ We extracted two 20mer
DNA sequences centered on each SNP identified between the
donor and recipient reference sequences that had in their 11th
position either the donor or recipient base. We challenged this
reference SNP library against a 20mer database created from
the FASTQ of the post-mating mixture using Jellyfish software
(Marçais and Kingsford, 2011). From the counts of the donor
and recipient 20mers at each base, we were able to (1) map
recombinant boundaries and (2) ascertain the extent of mixed
populations using R software (R Development Core Team, 2015).
Phylogenetic Analysis
Genes were aligned using PRANK (Löytynoja, 2014). The
R package Phangorn (Schliep, 2010) was used to calculate
maximum likelihood phylogeny using the Symmetric+GI model
(chosen based on best fit). Trees were bootstrapped 100 times.
MIC Determination (Tetracycline
Susceptibility In vitro) and tet(C) Stability
Assay
The MIC of all confirmed recombinants (by PCR and ompA
genotyping) was tested as described above. To further test the
stability of the recombinants regarding the presence of tet(C),
recombinants were grown at an MOI of 5. Cultures were passaged
five times before they were challenged or not with tetracycline
using three different conditions: (A) no tetracycline; (B) 1/2
MICTP of the recombinant; and (C) 4x MIC of the recombinant.
Following challenge, we propagated individual recombinants
once under each condition and determined the MIC. Condition
A was grown for another five passages (10 total) and was treated
similarly as for passage five. The MIC was determined again after
one additional passage. Additionally, DNA was extracted from
the samples of the recombinants obtained after every passage to
confirm that the ompA genotype was identical to the recombinant
prior to the start of the assay and to test for the presence of tet(C)
by PCR (Table 2).
RESULTS
Co-infection of S45 with Tetracycline
Resistant Strains R19 and R27 Does Not
Yield Recombinants
Previous studies have shown that co-infection of the tetR C. suis
strain R19 with a tetS C. trachomatis L2 strain results in tetR
C. trachomatis recombinants (Suchland et al., 2009; Jeffrey
et al., 2013). We aimed to obtain tet(C)-positive C. suis S45
recombinants by co-infecting S45 with three tetR C. suis strains
representing three of the four tet(C)-containing cassette Classes:
I (strain R19; complete cassette with all three segments); II
(strain Rogers132; without Segment 3); and IV (strain R27;
without Segment 1) (Figure 1). Eight co-infections with R19
were performed using various protocols, including infection
with R19 at 8 or 24 h pi with S45, and pre-treatment of R19
with high doses of tetracycline prior to co-infection. These co-
infections tested negative for S45 by PCR using primers specific
for the IGR of pmpB/C and by ompA genotyping (Supplementary
Table S1) after tetracycline challenge, and were not further
investigated. S45 was further grown in shell vials prior to co-
infection with R19 (MOI 0.5) at 9 h pi and challenged with
0.25 µg/mL tetracycline. These infections were mixed; however,
the 21 inclusions picked via harvest assay either resulted in
cultures only positive for R19 by PCR and ompA genotyping or in
cultures positive for only R19 after two passages (data not shown).
One R27 co-infection with S45 was performed and yielded no
recombinants.
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TABLE 2 | List of potential recombinants and their antibiotic susceptibility profiles.
Name Parental strains Protocol 1 or 2 Tetracycline
condition A, B, or C
ompA genotype/132 pmpC
PCR/S45 pmpB/C IGR PCR
tet(C) PCR MIC (µg/mL)
Rec 2 S45/132a (1) 24 hpi, 2 µg/mL (A) no tetracycline S45/−/S45 Positive 0.125
Rec 3b S45/132 (1) 24 hpi, 2 µg/mL (B) 1/2 MICTp S45 S45/−/S45 Positive 8
Rec 4b S45/132 (1) 24 hpi, 2 µg/mL (B) 1/2 MICTp S45 S45/−/S45 Positive 8
Rec 5b S45/132 (2) Co-inf., 0.25 µg/mL (B) 1/2 MICTp S45 132/−/S45 Positive 4
Rec 6 S45/132 (2) Co-inf., 0.25 µg/mL (C) 2x MIC S45 132−S45/132/− Positive 8
Rec 7 S45/132 (2) Co-inf., 0.25 µg/mL (C) 2x MIC S45 S45/−/S45 Positive 4
Rec 8 S45/132 (2) Co-inf., 0.25 µg/mL (C) 2x MIC S45 S45/−/S45 Negative 0.064
aRogers132; btrue recombinant; (−), negative PCR.
FIGURE 1 | The structure of the tet(C)-containing cassette is comprised of three unique segments. Shown is the tet(C)-containing cassette and
neighboring genes, depending on the Class of cassette. The structure of the cassette comprises three diversely arranged segments (purple, red, and orange)
consisting of different genes. Four cassette types, termed Class I to IV, have been identified in 11 C. suis strains: (I) contains all three segments in the listed segment
order (R19 and R24); (II) the cassette of Rogers130 and Rogers132 is lacking segment 3, which contains transposases IS200 and IS605; (III) the cassette of H5 is
similar to that of cassette I but occurs in reverse segment order; (IV) is missing segment 1 (replication/mobilization protein genes). ftsK, DNA translocase gene; rrn
operon, consisting of 16S, 23S, and 5S rRNA; nqrF, Na(+)-translocating NADH-quinone reductase subunit F gene; yajC, preprotein translocase subunit gene;
methyltrans., putative RNA methyltransferase gene; repC, replication protein C gene; repA, replication protein A gene; H, hypothetical protein gene; T, Toxin mazF
gene; relaxase, conjugal transfer relaxase gene; CO, CO dehydrogenase maturation factor gene; ME, mobile element IS101; tetC, tetracycline resistant gene class C;
tetR, tetracycline repressor gene; tetracycline resistance protein class A from transposon 1721; tra., transposase (IS200); put. trans., putative transposase (IS605).
Using Sub-inhibitory Tetracycline
Concentrations, the tet(C) Cassette was
Transferred from Rogers132 to S45
Following Co-infection
Rogers132 (donor strain) and S45 (recipient strain) recombinants
were successfully generated by simultaneous or sequential co-
infection (see Materials and Methods). The success rate of
producing recombinants was low. We obtained seven putative
recombinants (Rec 2–8), which were propagated for whole-
genome sequencing following a second harvest assay (Table 2).
In genome analyses described below, several ‘recombinants’
turned out to be mixtures of strains or only parental strains,
but the original term is used to describe Rec 2–8. In detail,
for co-infection 1, 21 clones were Rogers132; 3 were S45
survivors or mixed infections (including Rec 2); and 2 were
true recombinants (Rec 3 and 4). For co-infection 2, 11 were
Rogers132; 18 were S45 or mixed infection (including Rec 6–
8); and one was a true recombinant (Rec 5). Rec 2 and 8
were tetracycline sensitive after propagation while Rec 6 was
positive for both S45 and Rogers132 by ompA genotyping and
for Rogers132 by pmpC PCR. Figure 2 shows the PCR results
for tet(C), pmpC and pmpB/C-IGR for the seven recombinants
(Supplementary Figure S2: original gel images). We only
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FIGURE 2 | Strain-specific PCR primers identify putative
recombinants. Shown are the PCR results of each putative recombinant
(Rec). Rec 6, a mixed population of S45 and Rogers132, displays a faint
positive band for Rogers132-specific pmpC (middle lane). All putative
recombinants were PCR positive for the S45-specific IGR between pmpB and
pmpC (top lane) and for tet[C], bottom row.
obtained putative recombinants from co-infections performed in
media containing sub-inhibitory (1/2 MICTP) or inhibitory (4x
MIC) concentrations of tetracycline for S45; no recombinants
were obtained without tetracycline. Only Rec 3, 4 and 5, all
originally grown in sub-inhibitory tetracycline concentrations,
were later confirmed as true recombinants by genomic analyses
(see below).
We evaluated whether confirmed recombinants Rec 3, 4,
and 5 remained stable over 10 passages without sub-inhibitory
concentrations of tetracycline. After five passages, recombinants
were either left drug-free (A) or challenged with low (B) and
high (C) doses of tetracycline with subsequent MIC analyses (see
Materials and Methods). For each recombinant, every passage
was collected and tested for the presence of tet(C). At passage
10, ompA genotyping was performed to exclude the possibility
of a small population of Rogers132 survivors. As expected, Rec
3, 4, and 5 remained positive for tet(C) with the identical ompA
genotype throughout the stability assay (data not shown). These
recombinants continued to be tetracycline resistant after passages
5 and 10 with relatively high MICs (Table 3; 8–16 µg/mL).
In contrast, putative recombinant Rec 7 was tet(C) positive
by PCR in the first five passages but negative in passages 6–10
with an S45 ompA sequence, while Rec 6 was tet(C) positive
throughout the assay and tetracycline resistant (Table 3).
All recombinants required propagation in 0.064 µg/mL
tetracycline (4x MIC S45) in order to produce tet(C)-positive
chlamydial stocks in sucrose phosphate glutamate (SPG) as
described (see Materials and Methods). Attempts to propagate
recombinants in the absence of tetracycline led to the loss
of the tet(C) cassette following serial passages. However, once
SPG stocks were produced, the confirmed recombinants were
consistently positive for tet(C) throughout the 10 passages in
the absence of tetracycline for the stability assay, and were
phenotypically resistant in vitro (MIC > 4 µg/ml).
One co-infection experiment was performed for each of the
two protocols under three different tetracycline Conditions: A–C
(see Table 2). For protocol 1, co-infections were used to infect
one 6-well plate per tetracycline Condition. Six to eleven clones
were picked (26 total) per plate, resulting in two confirmed
recombinants, Rec 3 and 4, from Condition B. For protocol
2, 30 clones were picked with 10 clones each per Condition,
resulting in one confirmed recombinant, Rec 5, from Condition
B. Taken together, only seven (12.5%) of 56 clones were identified
as putative recombinants, and three were confirmed (5.4%). For
Condition B, the success rate was 15.0% (3/20).
Altogether, we identified a number of Rogers132 clones
(21/26; 80.8%), few S45 survivors and/or mixed infection (3/26
including Rec 2; 11.5%) and two confirmed recombinants (Rec 3
and 4; 7.7%) using Protocol 1 (Supplementary Figure S1). This
can be explained by the lack of counter-selection used in this
study as we wished to observe the outcome of natural co-infection
with tetracycline as the only selection method. In contrast, the
second co-infection using Protocol 2 (Supplementary Figure S1)
yielded more S45 survivors or mixed infection (18/30 including
Rec 6–8; 60%), several Rogers132 clones (11/30; 36.7%) and only
one true recombinant (Rec 5; 3.3%), which can be explained
by the abundance of S45 growth in shell vials used for this co-
infection experiment as well as the lower dose of tetracycline
applied to eliminate S45 survivors (0.25 µg/ml).
Heterogeneity of tet(C) Cassette
Insertion into C. suis Strain S45
The seven putative recombinants described above were genome
sequenced (Supplementary Table S2). We made a database
of 4,864 SNPs between Rogers132 and S45 using parsnp
(Treangen et al., 2014) (Datasheet S1) and used them as
markers to distinguish potential recombination junctions in
raw sequence data (Figure 3, ‘SNP painting’: see Materials
and Methods). Aside from Rec 6, which was a mixture of
donor and recipient, the recombinants were predominantly
comprised of the S45 genetic backbone, evincing our success in
screening for the recipient following co-infection. Recombinant
regions were determined at the approximate junctions between
regions of ‘S45-like’ and ‘Rogers-like’ SNPs (Figure 3A). While
Rec 2 was PCR-positive for tet(C), there was undetectable
recombination based on genome sequence analysis. Similarly,
Rec 7 had no evidence for recombination. Rec 3 and 4
were confirmed recombinants with identical tet(C) cassette
insertion sites at Rogers132 coordinates of ∼705,300–760,600
(upstream and downstream cross-overs varied in length because
of sparse SNPs) in the S45 backbone, constituting ∼55,300
nucleotides (5.3% of the genome) including the rrn operons
of 16S, 23S, and 5S rRNAs. The insertion spans from the
Na(+)-translocating NADH-quinone reductase subunit F gene
(nqrF) to the phosphoenolpyruvate carboxykinase [GTP] gene
(pckG).
Rec 5 had a much larger insertion containing the
tet(C) cassette at Rogers132 coordinates ∼638,000–813,000
(Figures 3A,B, right plot), spanning the 2-dehydro-3-
deoxyphosphooctonate aldolase gene (kdsA) to the 3′(2′),
5′-bisphosphate nucleotidase gene (cysQ) in the S45 backbone.
This region constitutes 175,000 nucleotides (16.6% of the
genome). There were also second and third insertions within
Rogers132 coordinates 529,000–538,000 in the S45 backbone
(Figure 3B, left plot), including the putative general secretion
pathway protein D gene (gspD) to the secretion system effector
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TABLE 3 | Stability Assay for five putative recombinants, showing results for passage 5 (P5) and passage 10 (P10).
Name (tet[C] PCR) start to P5 (A) (tet[C] PCR) P5 (B/C) (tet[C] PCR) P6 to P10 MIC (µg/mL) P5 MIC (µg/mL) P10 ompA
Rec 3 +/+/+/+/+ +/+ +/+/+/+/+ 8 16 S45
Rec 4 +/+/+/+/+ +/+ +/+/+/+/+ 8 16 S45
Rec 5 +/+/+/+/+ +/+ +/+/+/+/+ 16 16 132a
Rec 6 +/+/+/+/+ +/+ +/+/+/+/+ 16 16 132a
Rec 7 +/+/+/+/+ +/− −/−/−/−/− 0.25 ND S45
aDenotes Rogers132. ND, not done.
FIGURE 3 | Identification of Rogers132 insertion(s) and mixed infections in putative recombinant genomes with ‘SNP painting.’ Plots recognizing
recombinant regions were created by distinguishing the two parental strains Rogers132 (red) and S45 (black) (see Materials and Methods). (A) Schematic of the
putative recombinants Rec 2, 3, 5–8 clockwise from top left exemplifying crossover regions in Rec 3 and 5; (B) Enlarged region of the two recombinant regions
found in Rec 5, and (C) Schematic representation of recombinant regions within Rec 6, a putative recombinant, which was a mixed infection. The SNP painting plot
of the Rec 6 co-infection shows the region that maps to Rogers132 between coordinates 800000 to 950000. The region between ∼856,780–884,340 has low to
zero coverage of Rogers132 type SNPs (red) and higher coverage of the S45, suggestive of recombination within the region. The Rogers132 strain donor has
acquired DNA from the S45 recipient.
C gene (sseC) family. The presence of a subpopulation of
S45-like SNPs across the 638,000–813,000 recombinant region
revealed that Rec 5 was a mixed culture, consisting of a majority
recombinant population and a minority of S45 recipient
containing no Rogers132 DNA.
Although Rec 6 was a mixture of donor and recipient
(Figure 3A), we identified a recombinant region of ∼40,000
nucleotides between Rogers132 coordinates ∼856,780–
884,340 (Figure 3C). These coordinates are in the pmpD
and phenylalanine t-RNA ligase (pheS) genes (Figure 3C). Rec
8 had no evidence of recombinants, consistent with the PCR
results (Figure 2), and was considered an S45 survivor.
Figure 4 shows the recombinant locations of the cassette and
other insertion sites within the context of the entire circular
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FIGURE 4 | Tet(C)-cassette insertions in the S45 genome are
heterogeneous. Shown are the sites of insertion (blue) for the three
confirmed recombinants, Rec 3/4 (top) and Rec 5 (bottom), in the circular S45
genome. PZ, plasticity zone (dark gray); cysQ,
adenosine-3′(2′),5′-bisphosphate nucleotidase; rrn, rrn operon (16S rRNA,
23S rRNA, 5S rRNA); nqrF, Na(+)-translocating NADH-quinone reductase
subunit F; pckG, phosphoenolpyruvate carboxykinase [GTP]; ompA, major
outer membrane protein A; kdsA, 2-dehydro-3-deoxyphosphooctonate
aldolase; gspD, Putative general secretion pathway protein D; hp, hypothetical
protein.
genome for Rec 3 and 4, and for Rec 5. While the cassette
was confirmed to reside within ilp and rrn operons for all 11
previously genome sequenced C. suis strains (Joseph et al., 2016),
the insertion in Rec 3 and 4 included nqrF, extending to pckG
beyond the downstream rrn operon. The upstream crossover is
located within ∼2.2 kb, either in pckG or its neighboring gene
downstream, encoding a hypothetical protein, and in proximity
to ribosomal bindings sites (RBSs), whereas the downstream
crossover is found within nqrF (Figure 5A).
For Rec 5, the cassette insertion spanned cysQ to kdsA, which
included the rrn operons and the ompA gene of Rogers132.
The upstream crossover is located within ∼750 bp between the
downstream end of kdsA or tRNA-Arg (tct) and a hypothetical
protein-encoding gene, while the downstream crossover is found
in cysQ, spanning 230 bp (Figures 4 and 5B). Both crossovers
are in proximity to RBSs, and palindromes are evident. We also
identified two shorter recombinant regions located adjacent to
each other between kdsA and pmpBC (Figure 4). The larger of
the two crossovers was found upstream within gpsD (∼380 bp)
and downstream, either in mutL or ipgC, spanning ∼3 kb
(Figure 6A), and in proximity to RBSs with evidence for
palindromes where one is at the site of the SNP at nucleotide
position 2230 (Figure 6A1). The complete crossover located
within the sseC-like gene family spanned 1500 bp (Figure 6B).
Figure 6C shows a schematic of the two Rogers132 insertions.
In examining the plasmids, all except Rec 7 had the S45
plasmid. Rec 6 was a mixture of both S45 and Rogers132
plasmids. None of the plasmids exhibited any genetic exchange.
DISCUSSION
Mutation, HGT, and genome rearrangement shape bacterial
genomes on an evolutionary time scale (Darmon and Leach,
2014). Most Chlamydia genomes, of which C. trachomatis
is the best studied species, show evidence of intra-species
recombination events (Millman et al., 2001; Gomes et al., 2007;
Jeffrey et al., 2010; Mitchell et al., 2010; Joseph et al., 2011,
2012, 2015, 2016; Harris et al., 2012; Joseph and Read, 2012;
Putman et al., 2013; Read et al., 2013; Bachmann et al., 2015)
but little to no evidence for classic HGT acquired pathogenicity
islands (Nunes and Gomes, 2014) or other foreign genes except
for bacteriophage inserts in Chlamydia pneumoniae (Rosenwald
et al., 2014) and genes possibly acquired in the plasticity zone
(Read et al., 2000; Liu et al., 2007). The most notable exception
to this rule is C. suis, which is not only known for the possession
of the tet(C)-containing cassette (Dugan et al., 2004), but has
recently been shown to be highly recombinogenic compared to
other Chlamydia species (Joseph et al., 2016).
To date, four classes of tet(C)-containing cassettes have been
described (Donati et al., 2014; Joseph et al., 2016). The cassettes
are inserted at an identical site within the chromosomal invasin
gene (called ilp or inv-like gene) flanked upstream by an rrn
operon and downstream by the gene nqrF (Dugan et al., 2004;
Joseph et al., 2016). It is likely that the cassette originated
from one ancestral transposition event, although other options
are possible (Joseph et al., 2016). TetS strain S45 possesses the
intact ilp gene, which is conserved within the C. suis species
(Supplementary Figure S3) (Donati et al., 2016) but also found
in C. caviae strain GPIC [AE015925.1], sharing 73% identity
and 91% query cover by BLASTN (Liu et al., 2007). No other
Chlamydia species or other known species contains this gene.
These data suggest that ilp is required for cassette insertion.
However, Suchland et al. (2009) demonstrated that C. muridarum
strain MoPn and C. trachomatis strain L2, both of which lack ilp,
are able to acquire the cassette in vitro by co-infection with C. suis
strain R19, while C. caviae was not receptive.
In a follow-up study, Jeffrey et al. (2013) co-infected tet(C)-
positive and -negative L2 recombinants from the former study
with non-LGV C. trachomatis strains F and J to produce new tetR
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FIGURE 5 | Recombinant crossover regions in Rec 3 and 4, and Rec 5 based on sequence alignments with S45 and Rogers132. Shown are the
nucleotide sequences of the crossovers up- and down-stream for Rec 3 and 4 (A) and the large insertion of Rec 5 (B). Numbers on top of the sequences represent
the positions relative to the respective gene. Gene IDs (e.g., CS00631) refer to the annotation of Rogers132. Crossover regions are highlighted in gray with SNPs
indicated in magenta if the recombinants aligned to the S45 backbone and in green if they aligned to Rogers132. Palindromes are indicated by blue letters, while
tRNAs are highlighted in light gray with white letters. The tRNA associated inverted repeats are highlighted in blue with white letters. Putative ribosomal binding sites
(RBS) are highlighted in red and further indicated by “-RBS-” on top of the nucleotide sequence.
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FIGURE 6 | Recombinant crossover regions for the two small insertion for Rec 5 based on sequence alignments with S45 and Rogers132. Shown are
the nucleotide sequences of the small insertion of Rec 5. (A) Represents the slightly longer region upstream, while (B) shows the shorter crossover region
downstream. Numbers on top of the sequences represent the positions relative to the respective gene. Gene IDs (e.g., CS00631) refer to the annotation of
Rogers132. Crossover regions are highlighted in gray with SNPs indicated in magenta if the recombinants aligned to the S45 backbone and in green if they aligned
to Rogers132. Blue letters indicate palindromes while putative RBS are highlighted in red and further indicated by “-RBS-” on top of the nucleotide sequence.
(C) Shown is the schematic overview of the two small crossover regions.
recombinants. Neither study found specific nucleotide sequences
that suggested a mechanism for in vitro recombination, although
the cassette between the rrn operons of R19 was inserted into the
downstream rrn operon of L2. In addition to a similar localization
of the cassette in the rrn operon, Jeffrey et al. (2013) identified
what appeared to be non-specific recombination (190 events
in 12 recombinant strains) throughout the genome, unlike the
R19/L2 recombinants, suggesting that the progeny may have
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contained mixed infections despite selection of clones by limiting
dilution.
In contrast to the successfully produced tetR C. trachomatis
L2 and C. muridarum recombinants with R19 (Suchland
et al., 2009), we were unable to produce any tet(C)-positive
C. suis S45 recombinants after co-infection with R19. Similarly,
co-infections with R27 were unsuccessful because R27 outgrew
S45 within 2–3 passages. These observations were surprising
especially if we consider that resistance-determining accessory
resistance genes are thought to generally impair rather than
promote biological fitness of bacteria in the absence of antibiotics
(Andersson and Levin, 1999). One possible explanation is that
S45 was isolated in the 1960s and adapted to cell culture in
the laboratory, whereas the tetR strain donors have only been
cultured since the 1990s. To test this hypothesis, other Class
I and IV C. suis strains with a similar cassette would have
to be co-infected with a more recently isolated tetS C. suis
strain.
As opposed to previous co-infection studies, we implemented
three different tetracycline conditions and included S45
sub-inhibitory (0.004 µg/mL) and inhibitory (0.032 µg/mL)
tetracycline concentrations. Suchland et al. (2009) performed
co-infections without antibiotics prior to challenge with high-
dose tetracycline. Our conditions were based on the hypothesis
that low concentrations of antibiotics promote the selection
toward resistant bacteria (Cantón and Morosini, 2011). Indeed,
all three confirmed recombinants (Rec 3, 4, and 5) were
originally grown in sub-inhibitory concentrations, suggesting
that mating is optimized by a multiplicity of donors. Only
one putative recombinant was isolated from cultures that were
not initially grown in tetracycline, which was later confirmed
as an S45 survivor (Rec 2). To confirm that sub-inhibitory
concentrations of tetracycline promote the transfer of the
tet(C) cassette, quantitative analysis would be necessary. For
example, replicates of independent co-infection experiments
could be performed with 20–30 clones picked per tetracycline
condition instead of 6–10 as in our study. The number of
recombinants could then be compared among tetracycline
conditions.
Dugan et al. (2007) previously proposed that one or both
IS605 transposases were responsible for integration of the cassette
into the C. suis chromosome. While the initial HGT event that
brought the ancestral tet(C)-containing cassette into C. suis
probably involved transposition, we were able to demonstrate
that transfer of the cassette between C. suis was through
double crossover homologous recombination. This suggests that
homologous recombination has been a significant factor in the
recent spread of tetracycline resistance among C. suis strains
where 89–100% are resistant in the US, Europe and the Middle
East (Dugan et al., 2004; Di Francesco et al., 2008).
The boundaries of our recombinants were not near the
duplicated rrn operons as in the tetR C. trachomatis recombinants
and one of 12 sequenced recombinants described by Suchland
et al. (2009) and Jeffrey et al. (2013), respectively, but rather in
conserved, syntenic genome regions (Figures 5 and 6). In our
previous study, comparative genomics was used to infer that
putative ancestral recombination had occurred at high frequency
across theC. suis genome (Joseph et al., 2016). The recombination
boundaries in Rec 3 and 4 were identical, suggesting they
arose from sibling plaques rather than independent events, and
overlapped genes in recognized recombinant regions (CS00632
and CS00678) (Joseph et al., 2016), but the large Rec 5
recombination region did not (genes CS00570–572, CS00715).
Furthermore, small insertions in Rec 5 were incorporated
within one non-recombinant (CS00485) and two recombinant
regions (CS00482, CS00488–489). It is unclear, with our limited
number of C. suis genomes to compare to date, whether the
observed patterns reflect selection, recombination hotspots or
are purely stochastic. In inspecting the regions, inverted repeats,
chi sites or direct target repeats that are typical permissive sites
for recombination were not detected. However, the upstream
crossover in Rec 5 contained a tRNA (Figure 5B). These genes
are known to be acquired and involved in recombination for
a diversity of bacteria (Bishop et al., 2005; McDonald et al.,
2015). Conserved regions such as RBSs, which were present
within or near each cross-over region in our study (Figures 5
and 6), may also facilitate homologous recombination because
gene function would not be altered, allowing new recombinants
to be successful (Gomes et al., 2007) as in the present study.
A similar lack of patterned recombination was noted in a recent
study of beta-lactam and vancomycin resistance in Enterococcus
faecium, in which the authors hypothesized that long sequences
of highly homologous DNA were targets for recombination
(García-Solache et al., 2016). Since at least 89% of C. suis strains
isolated from farm animals are tetR (Andersen and Rogers,
1998; Di Francesco et al., 2008) and C. suis shares 79.8%
average nucleotide identity with C. trachomatis, the potential for
homologous recombination and cassette transfer are high.
In summary, we present a co-infection model that produces
recombinants, demonstrating for the first time that the tet(C)-
containing cassette is transferred between C. suis strains by
homologous recombination without the need for IS200/IS605
transposases (Cassette Segment 3). We also discovered that,
while the frequency of recombination is low, sub-inhibitory
concentrations of tetracycline may promote transfer and that,
rather than targeting highly polymorphic regions, recombination
occurs in long homologous sequences and genomic regions with
tRNAs. Our model will serve as a template for determining the
mechanisms and frequency of cassette transfer among Chlamydia
species including C. trachomatis that may co-infect humans
at the same anatomic sites as tetR C. suis zoonotic strains.
Cassette transfer would have major implications for public health
approaches to treatment for humans and domesticated animals
alike.
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